Ohio Couple Files Xarelto Lawsuit Alleging Drug Caused Internal Bleeding

TheProductLawyers.com reports on the number of lawsuits that have been filed against the manufacturers of the blood-thinning drug Xarelto, Janssen Pharmaceuticals, a subdivision of the Johnson and Johnson Corporation, and Bayer AG. There have been more than 3,400 suits filed from across the United States since the U.S. Food and Drug Administration (FDA) approved the drug in 2011. Plaintiffs claim that the anticoagulant puts patients at a higher risk of experiencing dangerous and life-threatening bleeding episodes. Many of them have proven fatal. The plaintiffs in these cases also claim that the makers of the drug did not fully disclose to the public and to medical professionals prescribing the drug of the dangerous side effects that could ensue from taking it.

The purpose of Xarelto is to treat patients suffering from deep vein thrombosis (DVT), pulmonary embolism,and atrial fibrillation as well as those who are recovering from hip and knee replacement surgeries.

One of the 3,400 cases was filed by an Ohio couple who allege Xarelto caused the wife to experience a life-threatening gastrointestinal bleeding episode. She was taking Xarelto to minimize the chance of having a stroke because of her atrial fibrillation. The couple's court documents state that only after two months taking Xarelto, she developed internal bleeding, as well as anemia, and some other unidentified medical conditions. The couple also claims the bleeding has caused the need for long-term medical care and supervision.

It should be noted as well, that the US. Food and Drug Administration (FDA) has made note of these bleeding reports linked to Xarelto use. The agency has issued two black box warnings which are the harshest warnings a product can receive and could cause it to be totally removed from the market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.